PHGDH-inactive

CAS No. 1914971-16-6

PHGDH-inactive( —— )

Catalog No. M27683 CAS No. 1914971-16-6

PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
5MG 30 In Stock
10MG 52 In Stock
25MG 113 In Stock
50MG 178 In Stock
100MG 256 In Stock
200MG 359 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PHGDH-inactive
  • Note
    Research use only, not for human use.
  • Brief Description
    PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
  • Description
    PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    hCE2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1914971-16-6
  • Formula Weight
    327.45
  • Molecular Formula
    C17H21N5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (254.48 mM)
  • SMILES
    Cc1cc(C)nc(NC(=S)N2CCN(CC2)c2ccncc2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhen-Peng Mai, et al. Biotransformation of alisol G by Penicillium janthinellum and the hCE2 inhibitory effects of its metabolites. Phytochemistry Letters, Volume 13, September 2015, Pages 228–233.
molnova catalog
related products
  • Br-C10-methyl ester

    Br-C10-methyl ester is a PROTAC linker, which refers to the alkyl/ether composition. Br-C10-methyl ester is used in the synthesis of a series of PROTACs (MS432).

  • Eliglustat hemitartr...

    Eliglustat Hemitartrate, with an IC50 of 24 nM, is a specific, potent, oral active glucocerebral glycosidase inhibitor.Eliglustat tartrate shows good potency with an IC50 of 24 nM and specificity against the target enzyme.A novel inhibitor of glucosylceramide synthase (Genz-112638) and assessed its activity in a murine model of Gaucher disease (D409V/null).?Biochemical characterization of Genz-112638 showed good potency (IC(50) approximately 24nM) and specificity against the target enzyme.?

  • DLinDAP

    DLinDAP (D-LinDAP) is an ionizable cationic lipid used for SiRNA delivery.